|
03 Aug 2020 |
Novartis Cosentyx® receives EU approval for first-line systemic treatment in pediatric psoriasis
|
|
03 Aug 2020 |
Lilly Initiates Phase 3 Trial of LY-CoV555 for Prevention of COVID-19 at Long-Term Care Facilities in Partnership with the National Institute of Allergy and Infectious Diseases (NIAID)
|
|
02 Aug 2020 |
Genmab Announces European Myeloma Network and Janssen Achieve Positive Topline Results from Phase 3 APOLLO Study of Daratumumab in Combination with Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
|
|
02 Aug 2020 |
FDA Approves Monjuvi(R) (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
|
|
31 Jul 2020 |
U.S. Food and Drug Administration Approves STELARA® (ustekinumab) for Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
|
|
31 Jul 2020 |
SAB Biotherapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of SAB-176 for Seasonal Influenza
|
|
31 Jul 2020 |
FDA Approves Genentech’s Tecentriq plus Cotellic and Zelboraf for People With Advanced Melanoma
|
|
30 Jul 2020 |
Merck Announces Two US Regulatory Milestones for KEYTRUDA® (pembrolizumab) in Triple-Negative Breast Cancer (TNBC)
|
|
30 Jul 2020 |
Nirsevimab reduced respiratory syncytial virus infections and hospitalisations in preterm infants in Phase IIb trial
|
|
30 Jul 2020 |
NEJM Study Demonstrates Safety and Efficacy of First Novel Monoclonal Antibody Specifically Developed to Treat Yellow Fever
|
|
29 Jul 2020 |
Henlius and Accord Healthcare Receive EMA Approval for Zercepac®, trastuzumab biosimilar
|
|
29 Jul 2020 |
Ridgeback Biotherapeutics LP Announces Priority Review of Biologics License Application for ansuvimab Ebola Treatment
|
|
29 Jul 2020 |
BARDA Procures Regeneron's REGN-EB3 Investigational Ebola Treatment for National Preparedness
|
|
29 Jul 2020 |
Genentech Provides an Update on the Phase III COVACTA Trial of Actemra in Hospitalized Patients With Severe COVID-19 Associated Pneumonia
|
|
29 Jul 2020 |
UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer’s Disease
|
|
28 Jul 2020 |
Grifols delivers first manufactured batches of its anti-SARS-CoV-2 hyperimmune globulin for clinical trials
|
|
27 Jul 2020 |
NGM Bio Announces Initiation of Phase 2 CATALINA Study of NGM621 in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
|
|
27 Jul 2020 |
European Commission grants marketing authorisation for world’s first subcutaneous formulation of infliximab, Remsima® SC, for an additional five indications including for use in inflammatory bowel disease and ankylosing spondylitis
|
|
27 Jul 2020 |
Centus Biotherapeutics Announces Positive CHMP Opinion for FKB238, Biosimilar Bevacizumab
|
|
27 Jul 2020 |
Imfinzi recommended for approval in the EU by CHMP for extensive-stage small cell lung cancer
|
|
27 Jul 2020 |
Daiichi Sankyo and AstraZeneca Enter New Global Development and Commercialization Collaboration for Daiichi Sankyo’s ADC DS-1062
|
|
24 Jul 2020 |
GSK receives positive CHMP opinion recommending approval of belantamab mafodotin for the treatment of relapsed and refractory multiple myeloma
|
|
24 Jul 2020 |
Kyowa Kirin Receives Positive CHMP Opinion for the Expanded Use of CRYSVITA® (burosumab) to Include Older Adolescents and Adults for the Treatment of X-Linked Hypophosphataemia (XLH)
|
|
24 Jul 2020 |
Sobi will file for a re-examination of emapalumab in Europe following negative opinion by CHMP
|
|
24 Jul 2020 |
Novartis Adakveo® receives positive CHMP opinion for the prevention of recurrent vaso-occlusive crises in patients with sickle cell disease
|
